Elevance Health Inc (ELV) Annual Income Statement

Annual · GAAP · USD millions
Access ELV quarterly income statements →
Reviewing income statement figures over time helps illustrate how Elevance Health Inc generates earnings and manages operating expenses.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
2025
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Premiums Earned, Net164,639.00
Revenue From Contract With Customer Excluding Assessed Tax24,470.00
Other Revenue8,475.00
Total Revenue199,125.00
Costs & Expenses
Cost of Goods and Services Sold21,178.00
Policyholder Benefits and Claims Incurred, Net148,223.00
Gross Profit29,724.00
Selling, Administration, Marketing20,984.00
Gain (Loss) on Disposition of Assets and Investments0.00
Depreciation & Amortization628.00
Restructuring, Accretion & Impairment Charges0.00
Other Operating Expense / Income1,402.00
Operating Costs192,415.00
Interest Expense0.00
Net Interest Expense / Income0.00
Extinguishment of Debt0.00
Other Loss / Income0.00
Total Costs & Expenses192,415.00
Income & Taxes
Income / Loss Before Income Taxes6,710.00
Income Taxes Expense / Benefit1,049.00
Income After Income Taxes5,661.00
Income / Loss from Continuing Operations5,661.00
Net Income / Loss5,661.00
Non-controlling Interests1.00
Income / Loss Attributable to Shareholders5,662.00
EBIT6,710.00
EBITD8,256.00
EBITDA8,256.00
Earnings Per Share
Basic EPS (excl. extra items)25.28
Basic Net EPS25.28
Basic shares outstanding (Mill. of Units)224.00
Diluted Net EPS25.21
Diluted average shares (Mill. of Units)224.60
Dividend per share6.81
4 historic quarters locked

Sign in to unlock the full Elevance Health Inc income statement history.

About Elevance Health Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: February 6, 2026
  • Original filing: elv-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.